Cryogenx’s patent-pending technology features a powerful coolant stored within compact cylinders that is injected into an adhesive, thermally conductive pad placed on the patient’s torso.
Cryogenx has raised €2.8M across 2 funding rounds from 6 investors, most recently a Seed round in Jul 2025. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-07-17 | Seed | €1.9M | Future Planet Capital,The UK Innovation & Science Seed Fund (UKI2S) | View deal → |
| 2024-06-26 | Other | €947k | Angel Investors,Existing Shareholders,The British Design Fund,US-based fund | View deal → |
